Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001199835-22-000838
Filing Date
2022-12-19
Accepted
2022-12-19 17:05:05
Documents
43
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 09/30/2022 10-K pkph093022-10k.htm   iXBRL 10-K 639673
2 CERTIFICATION pkph093022-ex31_1.htm EX-31.1 16680
3 CERTIFICATION pkph093022-ex31_2.htm EX-31.2 17297
4 CERTIFICATION pkph093022-ex32_1.htm EX-32.1 5525
5 CERTIFICATION pkph093022-ex32_2.htm EX-32.2 5652
  Complete submission text file 0001199835-22-000838.txt   2391072

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pkph-20220930.xsd EX-101.SCH 18424
7 XBRL CALCULATION FILE pkph-20220930_cal.xml EX-101.CAL 22444
8 XBRL DEFINITION FILE pkph-20220930_def.xml EX-101.DEF 44389
9 XBRL LABEL FILE pkph-20220930_lab.xml EX-101.LAB 149135
10 XBRL PRESENTATION FILE pkph-20220930_pre.xml EX-101.PRE 120909
37 EXTRACTED XBRL INSTANCE DOCUMENT pkph093022-10k_htm.xml XML 223375
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-53855 | Film No.: 221471914
SIC: 2834 Pharmaceutical Preparations